|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 9/145 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/2846 | (2013.01) | ||
| A61K 9/4808 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/485 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/475 | (2013.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Patento numeris | 2575785 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11727917.4 |
| Europos patento paraiškos padavimo data | 2011-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/002763 |
| Data | 2011-06-01 |
| (87) | Numeris | WO 2011/151086 |
| Data | 2011-12-08 |
| (30) | Numeris | Data | Šalis |
| 11075046 | 2011-03-14 | EP | |
| 10005762 | 2010-06-02 | EP |
| (72) |
PATZAK, Ulrich , NL
OUATAS, Taoufik , NL
|
| (73) |
Pharma& Schweiz GmbH ,
Riedstrasse 1, 6330 Cham,
CH
|
| (54) | ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF |
| ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF |